Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds quotes, detail, context)JOHANNESBURG, Feb 7 (Reuters) - South Africa will suspend use of AstraZeneca's COVID-19 shot in its vaccination programme after data showed it gave minimal protection against mild to moderate infection caused by the c...
Read more* Health workers were due to get AstraZeneca jabs soon* Trial data show significantly reduced protection vs variant* Johnson & Johnson, Pfizer shots to be offered instead* Scientists say vaccination strategy needs to change (Adds quotes, data detai...
Read moreJOHANNESBURG, Feb 7 (Reuters) - South Africa will suspend use of the AstraZeneca vaccine in its immunisation programme while scientists advise on the best way to proceed, Health Minister Zweli Mkhize said on Sunday.Mkhize was speaking after trial ...
Read moreBy Ruma PaulDHAKA, Feb 7 (Reuters) - Bangladesh launched a nationwide COVID-19 vaccination drive with the Oxford University-AstraZeneca vaccine on Sunday, aiming to inoculate 3.5 million people in the first month.The south Asian country is seeking...
Read more
(Sharecast News) - Vaccines Minister Nadhim Zahawi today said AstraZeneca is 'confident' its jab prevents serious illness caused by the South African coronavirus variant after early data from a small study suggested the vaccine was less effective against the strain. Mr Zahawi said he had spoken to England's Deputy Chief Medical Officer Jonathan Van Tam this morning about the study as he insisted the vaccine 'does protect against severe disease'. He said that through its own trials AstraZeneca is 'confident that it does effectively deal with serious illness, serious disease and hospitalisation'. - Financial Mail on Sunday
Read more* Minister expects annual vaccinations may be needed* Govt not planning vaccine passports -Nadhim Zahawi* UK reports a further 15,845 cases, 373 deaths (Adds latest figures, line on vaccine passports)By Costas PitasLONDON, Feb 7 (Reuters) - A COVID-...
Read more(Adds details)LONDON, Feb 7 (Reuters) - A COVID-19 booster in the autumn and then annual vaccinations are very probable, Britain's vaccine deployment minister said on Sunday as countries race to administer injections in the face of new variants.Br...
Read moreLONDON, Feb 7 (Reuters) - A COVID-19 booster and annual vaccinations are very probable, vaccine deployment minister Nadhim Zahawi said on Sunday as countries race to administer jabs in the face of new variants."We see very much probably an annual ...
Read more
First Oxford-AstraZeneca Jabs Arrive In Ireland
Read moreStudy Shows Oxford-AstraZeneca Jab Less Effective Against SA Mutation
Read more(Corrects spelling in first paragraph to AstraZeneca, not AztraZeneca)By Abdul Qadir SediqiKABUL, Feb 7 (Reuters) - Afghanistan received 500,000 doses of AstraZeneca's COVID-19 vaccine from India on Sunday, the first to arrive in the country, whic...
Read more(Adds details)By Derek Francis and Andy BruceFeb 6 (Reuters) - British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South Af...
Read more(Adds details)Feb 6 (Reuters) - British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, base...
Read moreLONDON, Feb 6 (Reuters) - British drugmaker AstraZeneca said on Saturday it believed its COVID-19 vaccine developed with the University of Oxford could protect against severe disease caused by the South African variant of the virus.AstraZeneca con...
Read moreFeb 6 (Reuters) - The COVID-19 vaccine developed by AstraZeneca and Oxford University does not appear to protect against mild and moderate disease caused by the South African coronavirus variant, the Financial Times reported on Saturday, citing a...
Read more
Last checked at